跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
MED-BRIMONIDINE - Health Canada Drug Approval Details
Approvals
/
Health Canada
/
MED-BRIMONIDINE
Authorized
STANDARD
MED-BRIMONIDINE
generic medical partners inc
🇨🇦 Health Canada
Approval Date
Jul 4, 2025
Approval ID
b2abecd36768811e
Company
generic medical partners inc
Type
Standard
Approval Details
Approval Id
b2abecd36768811e
Drug Approval Canada Name
MED-BRIMONIDINE
Product Name
MED-BRIMONIDINE
Status
Marketed
Status Date
2021-11-26
Original Market Date
2021-11-26
Din
02507811
Drug Class
Human
Dosage Form
Solution
Route Of Administration
Ophthalmic
Schedule
Prescription
Ahfs
52:40.04
Atc Original
S01EA05 BRIMONIDINE
Atc Name
s 01 ea 05
Aig Number
0131859001
Company Name
generic medical partners inc
Company Address
1500 Don Mills Road, Suite 711, Toronto, Ontario, Canada, M3B 3K4
Active Ingredients
BRIMONIDINE TARTRATE
0.2 % / W/V
Authorized
Quick Info
Agency
Health Canada
Country
🇨🇦
Approval Date
Jul 4, 2025
Approval ID
b2abecd36768811e
Type
Standard
Back to Health Canada Approvals